We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Over Prescription Drugs: Top 300

★★★★★ Alles wat u moet weten over de top 300 meest voorgeschreven medicijnen.

Learning essential information about the top 300 prescription drugs doesn’t have to be tedious. With Prescription Drug Cards: Top 300, you’ll get a comprehensive, easy-to-use study tool that will tell you everything you need to know about these most-prescribed drugs. And as a bonus, you’ll get the top 100 non-prescription drugs, too. This tool is ready to go with quick image and information retrieval—no Internet connection necessary!

Features:

You’ll learn crucial information about the top 300 prescription drugs, including:

✓ Generic and common name

✓ Class

✓ Dosage Forms

✓ Approved Dose and Indications

✓ Off-Label Use

✓ Contraindications

✓ Adverse Reactions

✓ Drug Interactions

✓ Monitoring Parameters

✓ Medication Safety Issues and Black Box Warnings

Learn vital drug information: Download Prescription Drug Cards: Top 300!

Wat is er nieuw in de nieuwste versie 4.70.2291

Last updated on May 16, 2017

This version includes a few improvements to make your study experience smoother.

Let us know what you think by emailing us at [email protected] or by leaving a 5-star review.

Vertaling Laden...

Aanvullende APP -informatie

Laatste Versie

Verzoek update van Prescription Drugs: Top 300 4.70.2291

Geüpload door

Marvin Guerrero Fernandez

Android vereist

Android 5.0+

Meer Info

Prescription Drugs: Top 300 Screenshots

Ook beschikbaar voor andere platforms

Talen
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succesvol ingeschreven!
Je bent nu geabonneerd op APKPure.
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succes!
Je bent nu geabonneerd op onze nieuwsbrief.